Connection

Lauge Østergaard to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Lauge Østergaard has written about Antiretroviral Therapy, Highly Active.
Lauge Østergaard
Connection Strength
0.273
Antiretroviral Therapy, Highly Active
  1. Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):386-393.
    View in: PubMed
    Score: 0.124
  2. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin. AIDS. 2018 07 31; 32(12):1729-1731.
    View in: PubMed
    Score: 0.121
  3. Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 Jun 15; 64(12):1686-1695.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.